Table 2 Characteristics of migraine in patients with and without insulin resistance
Migraine patients with insulin resistance (n = 14) | Migraine patients without insulin resistance (n = 16) | P-value | ||
|---|---|---|---|---|
Attack duration in hours [median (IQR)] | 12 (11–14) | 9 (6.5–15) | 0.22 1 | |
Aura [n (%)] | 3 (21.4%) | 4 (25%) | 0.818 2 | |
Autonomic manifestations [n (%)] | 1 (7.1%) | 1 (6.3%) | 0.922 2 | |
Allodynia [n (%)] | 4 (28.6%) | 5 (31.3%) | 0.873 2 | |
MIGSEV Scale [median (IQR)] | Intensity | 3 (3–4) | 2 (2–3) | 0.005* 1 |
Disability | 3 (3–3) | 2.5 (2–3) | 0.12 1 | |
Tolerability | 2 (2–3) | 2 (1–2) | 0.005* 1 | |
Nausea | 2.5 (2–4) | 2 (1–3) | 0.188 1 | |
Total score | 3 (2–3) | 1.5 (1- 2.75) | 0.002* 1 | |
HIT-6 total score [median (IQR)] | 63 (58.25–64.25) | 55.5 (42- 61.25) | 0.018* 1 | |